For more information on the new features, see the New features page.
This item is authorised by the following title:
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2024 (No. 1)
National Health Legislation Amendment (Extension of Closing the Gap – PBS Co-payment Program) Instrument 2024
National Health Legislation (Repeal and Consequential Amendments) Instrument 2024
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 2)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2023 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment (Mecasermin and Somatrogon) Instrument 2022
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2022 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 2)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2021 (No. 1)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2020 (No. 1) (PB 6 of 2020)
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2019 (No. 3) (PB 109 of 2019)
